We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hypothermia Increases Blood Loss During Surgery

By HospiMedica staff writers
Posted on 14 Jan 2008
A new study offers convincing evidence that even mild hypothermia during surgery increases blood loss significantly, as well as transfusion requirement.

Researchers at The Cleveland Clinic (OH, USA) conducted a systematic search of randomized trials published between 1966 and 2006 that compared blood loss and transfusion requirements in normothermic and mildly hypothermic (34-36 ºC) surgical patients, and analyzed the results. More...
Results were expressed as a ratio of the means--or relative risks--and 95% confidence intervals (CI). In all, 14 studies were included in analysis of blood loss, and 10 in the transfusion analysis.

The results showed that the median temperature difference between the normothermic and hypothermic patients among studies was 0.85 ºC (0.60 ºC versus 1.1 ºC). The ratio of geometric means of total blood loss in the normothermic and hypothermic patients was 0.84 (0.74 versus 0.96). Normothermia also reduced transfusion requirement, with an overall estimated relative risk of 0.78. The findings indicate that even mild hypothermia (less than 1 ºC) significantly increases blood loss by approximately 16%, and increases the relative risk for transfusion by approximately 22%. The study was published in the January 2008 issue of the journal Anesthesiology.

"When all the studies were evaluated together, the results clearly show that even very mild hypothermia increases blood loss and transfusion requirements by clinically important amounts,” concluded lead author Daniel I. Sessler, M.D., and colleagues.

All anesthetics interfere with the systems that naturally regulate body temperature; consequently, body temperature decreases in surgical patients who are not actively warmed. Hypothermia has long been known to increase the risk of heart attacks adverse myocardial events and infection, and prolongs recovery from surgery. However, anesthesiologists and the physicians responsible for monitoring patients' vital signs during surgery are able to control temperature easily, at low cost, and with virtually no risk to patients.


Related Links:
The Cleveland Clinic

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.